Your browser doesn't support javascript.
loading
Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review.
Tsunoda, Misuzu; Adachi, Takeya; Nakajima, Yuuri; Yatomi, Yoshihiro; Shimizu, Tomoko; Nakasute, Katsuki.
Affiliation
  • Tsunoda M; Department of Dermatology, National Hospital Organization Saitama Hospital, Saitama, Japan.
  • Adachi T; Department of Dermatology, National Hospital Organization Saitama Hospital, Saitama, Japan.
  • Nakajima Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Yatomi Y; Keio Allergy Center, Keio University Hospital, Tokyo, Japan.
  • Shimizu T; Department of Medical Innovation and Translational Medical Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Nakasute K; Department of Dermatology, National Hospital Organization Saitama Hospital, Saitama, Japan.
J Allergy Clin Immunol Glob ; 3(4): 100323, 2024 Nov.
Article in En | MEDLINE | ID: mdl-39282615
ABSTRACT
Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Allergy Clin Immunol Glob Year: 2024 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Allergy Clin Immunol Glob Year: 2024 Document type: Article Affiliation country: Japan Country of publication: United States